Summer Sale
50% off Premium Yearly
TSE:GUD
Knight Therapeutics (GUD.TO)
Financials 
Technical Analysis 
Jun 15, 2026, 12:00 amThis summary was created by AI, based on 3 opinions in the last 12 months.
Knight Therapeutics, trading under the symbol GUD-T, has garnered mixed reviews from experts focusing on its performance. While the company holds potential, particularly with its niche strategy of acquiring 'orphaned' drugs, concerns have arisen regarding its ability to deliver consistent earnings. Despite positive management and beneficial operations in Brazil, the stock has displayed volatility, with current trading levels hovering around $5.75 to $6. Experts suggest a cautious approach, as there is speculation the stock could decline to approximately $5.14 if it fails to maintain support levels. Long-term investors may find themselves in a holding pattern, facing uncertainty about whether the stock will ultimately rebound or require a reassessment of their investment strategy.
Only on the market a couple of months. There are only two people in the company. A drug has just been approved. Thinks it will be very exciting.
Michael Smedley'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Got hit today because they are issuing warrants. Good opportunity to buy in right now. Has a lot of cash. Very interesting fundamental story. Technically it looks very strong as well.